ACUT Accustem Sciences, Inc.

Fundamentals / CIK 0001850767 / USD

Accustem Sciences, Inc. reported $83K in total assets and a net loss of $3.12M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACUT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$0$0$0-$3.50MFY 2021 Net Income: -$671K2021FY 2022 Net Income: -$3.75M2022FY 2023 Net Income: -$2.05M2023FY 2024 Net Income: -$1.51M2024FY 2025 Net Income: -$1.76M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $281K $138K $140K $267K $73K
Total Operating Expenses $1.76M $1.51M $2.05M $3.75M $671K
Operating Income -$1.76M -$1.51M -$2.05M -$3.75M -$671K
EBITDA -$1.76M -$1.50M -$2.05M -$3.74M --
Income Before Tax -$1.76M -$1.51M -$2.05M -$3.75M -$671K
Net Income -$1.76M -$1.51M -$2.05M -$3.75M -$671K
Basic EPS -$0.12 -$0.13 -$0.18 -$0.34 -$0.07
Diluted EPS -$0.12 -$0.13 -$0.18 -$0.34 --
Basic Shares Outstanding 15.2M 11.4M 11.3M 11.0M 10.0M
Diluted Shares Outstanding 15.2M 11.4M 11.3M 11.0M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- $98K -- -- -- -- -- --
Research & Development $14K $44K $120K $120K $73K $60K $28K $42K
Total Operating Expenses $1.87M $351K $486K $514K $400K $401K $440K $372K
Operating Income -$1.87M -$253K -$486K -$514K -$400K -$401K -$440K -$372K
EBITDA -- -- -- -$514K -$400K -$401K -$440K -$371K
Income Before Tax -- -- -$486K -$514K -$400K -$401K -$440K -$372K
Net Income -$1.87M -$253K -$486K -$514K -$400K -$401K -$440K -$372K
Basic EPS -$0.12 -$0.02 -$0.03 -- -$0.02 -$0.02 -$0.03 --
Diluted EPS -$0.12 -$0.02 -$0.03 -- -$0.02 -$0.02 -$0.03 --
Basic Shares Outstanding 16.1M 16.1M 16.1M -- 16.1M 16.1M 12.7M --
Diluted Shares Outstanding 16.1M 16.1M 16.1M -- 16.1M 16.1M 12.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $14K $5.0K $21K $734K --
Cash & Short-Term Investments $14K $5.0K $21K $734K --
Other Current Assets -- -- -- $30K --
Total Current Assets $49K $50K $130K $932K $1.35M
Property, Plant & Equipment, Net -- $418 $4.0K $7.7K --
Total Non-Current Assets $1.50M $418 $4.0K $7.7K $0
Total Assets $1.55M $51K $134K $940K $1.35M
Accounts Payable $704K $805K $578K $312K $389K
Other Current Liabilities $4.22M $2.37M $1.45M $142K --
Total Current Liabilities $4.95M $3.36M $2.25M $1.08M $703K
Total Non-Current Liabilities $0 $0 $0 $0 $0
Total Liabilities $4.95M $3.36M $2.25M $1.08M $703K
Common Stock $16K $12K $11K $11K $10.0K
Retained Earnings -$9.78M -$8.03M -$6.52M -$4.47M -$725K
Accumulated Other Comp. Income -- -- -- -- $67K
Total Stockholders' Equity -$3.40M -$3.31M -$2.11M -$140K $651K
Total Equity -$3.40M -$3.31M -$2.11M -$140K $651K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $15K $13K $12K $14K $14K $31K $36K $5.0K
Cash & Short-Term Investments $15K $13K $12K $14K $14K $31K $36K $5.0K
Other Current Assets -- -- -- -- $1.50M $1.50M $1.50M --
Total Current Assets $83K $106K $50K $49K $1.57M $1.61M $1.55M $50K
Property, Plant & Equipment, Net -- -- -- -- -- -- $105 $418
Total Non-Current Assets $0 $1.50M $1.50M $1.50M $0 $0 $105 $418
Total Assets $83K $1.61M $1.55M $1.55M $1.57M $1.61M $1.55M $51K
Accounts Payable $640K $616K $738K $704K $923K $860K $849K $805K
Other Current Liabilities $5.36M $5.02M $4.68M $4.22M $3.37M $3.07M $2.71M $2.37M
Total Current Liabilities $6.06M $5.72M $5.42M $4.95M $4.48M $4.15M $3.71M $3.36M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $6.06M $5.72M $5.42M $4.95M $4.48M $4.15M $3.71M $3.36M
Common Stock $16K $16K $16K $16K $16K $16K $16K $12K
Retained Earnings -$12.39M -$10.52M -$10.27M -$9.78M -$9.27M -$8.87M -$8.47M -$8.03M
Total Stockholders' Equity -$5.98M -$4.12M -$3.87M -$3.40M -$2.91M -$2.53M -$2.16M -$3.31M
Total Equity -$5.98M -$4.12M -$3.87M -$3.40M -$2.91M -$2.53M -$2.16M -$3.31M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$1.76M -$1.51M -$2.05M -$3.75M -$671K
Depreciation & Amortization $418 $3.6K $3.6K $3.3K --
Stock-Based Compensation $89K $70K $79K $134K $21K
Change in Payables -$101K $226K $267K -$77K $395K
Operating Cash Flow -$850K -$664K -$1.62M -$1.81M --
Capital Expenditure -- -- -- -$11K --
Free Cash Flow -- -- -- -$1.82M --
Investing Cash Flow -- -- -- -$11K --
Common Stock Issued -- -- -- $2.68M --
Financing Cash Flow $859K $648K $903K $2.55M --
Net Change in Cash $8.9K -$16K -$712K $734K --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.87M -$253K -$486K -$514K -$400K -$401K -$440K -$372K
Depreciation & Amortization -- -- -- $0 $105 $105 $313 $907
Stock-Based Compensation $7.4K $7.3K $15K $24K $24K $23K $18K $19K
Change in Payables $24K -$122K $34K -$219K $63K $11K $44K $14K
Operating Cash Flow -$241K -$249K -$374K $22K -$604K $22K -$290K $414
Financing Cash Flow $244K $250K $372K -$23K $587K -$27K $322K -$32K
Net Change in Cash $2.4K $721 -$1.7K -$463 -$17K -$5.0K $31K -$32K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -- -- -- -103.1%
Return on Assets (ROA) -113.3% -2959.8% -1531.5% -398.7% -49.6%
Current Ratio 0.01x 0.01x 0.06x 0.86x 1.93x
Quick Ratio 0.00x 0.00x 0.01x 0.68x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -3753.2% -102.9% -116.3% -113.3% -102.6% -95.6% -91.5% -2959.8%
Current Ratio 0.01x 0.02x 0.01x 0.01x 0.35x 0.39x 0.42x 0.01x
Quick Ratio 0.00x 0.00x 0.00x 0.00x 0.00x 0.01x 0.01x 0.00x
Operating Cash Flow Growth (YoY) -- -1253.8% -- +5300.2% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001850767) · from March 31, 2021 Data through September 30, 2026 · synced Nov 21, 2026, 05:12 UTC · Open in terminal